Butalbital, Aspirin, and Caffeine

CHEBI:CHEBI_749476

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

pharm_class
Decreased Platelet Aggregation [PE]
dea_schedule
CIII
pharm_class_cs
Xanthines [CS]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
active_ingredient_name
ASPIRIN
rxcui
2583731
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20241231
route
ORAL
marketing_category
ANDA
active_ingredient_strength
500 mg/1
dosage_form
CAPSULE
nui
N0000008832
pharm_class_epc
Platelet Aggregation Inhibitor [EPC]
pharm_class_moa
Cyclooxygenase Inhibitors [MoA]
unii
R16CO5Y76E
pharm_class_pe
Decreased Platelet Aggregation [PE]
marketing_start_date
19851011
package_marketing_start_date
19851011
labeler_name
Chartwell RX, LLC
manufacturer_name
Chartwell RX, LLC
generic_name
butalbital, aspirin, and caffeine
brand_name
butalbital, aspirin, and caffeine
brand_name_base
butalbital, aspirin, and caffeine
product_ndc
62135-433
application_number
ANDA078149
spl_id
06d3d1f9-7127-84b0-e063-6394a90a1aea
package_ndc
62135-433-90
package_description
90 CAPSULE in 1 BOTTLE (62135-433-90)
spl_set_id
e69d8bb1-ba09-42e2-8372-7f5e0a906174
upc
0362135433901